June 12, 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

November 5, 2024

In a seminar open to the public held on October 30, 2024, the BPTO announced that it will change its interpretation of … Brazilian PTO changes its understanding on the registration of “slogans” as trademarks

September 24, 2024

The Brazilian National Council for Scientific and Technological Development (CNPQ), through CNPQ Ordinance No. 1,935 (“Ordinance”), dated September 20, 2024, has established … Brazilian CNPQ defines Intellectual Property guidelines for funded inventions

September 19, 2024

Updates on procedures for transferring ownership and changing the name/company name, address/headquarters, and security interest or pledge of patent holders of any … Updates on procedures for ownership transfers and amendments to patent holder informations